[1]王晓刚.利拉鲁肽联合胰岛素泵对2 型糖尿病合并肝硬化患者血糖代谢及肝纤维化的影响[J].医学信息,2018,31(20):136-138.[doi:10.3969/j.issn.1006-1959.2018.20.041]
　WANG Xiao-gang.Effects of Liraglutide Combined with Insulin Pump on Blood Glucose Metabolism and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Complicated with Cirrhosis[J].Medical Information,2018,31(20):136-138.[doi:10.3969/j.issn.1006-1959.2018.20.041]
点击复制

利拉鲁肽联合胰岛素泵对2 型糖尿病合并肝硬化患者血糖代谢及肝纤维化的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年20期
页码:
136-138
栏目:
药物与临床
出版日期:
2018-10-15

文章信息/Info

Title:
Effects of Liraglutide Combined with Insulin Pump on Blood Glucose Metabolism and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Complicated with Cirrhosis
文章编号:
1006-1959（2018）20-0136-03
作者:
王晓刚
山东医学高等专科学校附属医院内分泌科，山东 临沂 276004
Author(s):
WANG Xiao-gang
Department of Endocrinology,Affiliated Hospital of Shandong Medical College,Linyi 276004,Shandong,China
关键词:
利拉鲁肽; 胰岛素泵; 肝硬化
Keywords:
Liraglutide; Insulin pump; Cirrhosis
分类号:
R587.1;R657.3+1
DOI:
10.3969/j.issn.1006-1959.2018.20.041
文献标志码:
A
摘要:
目的 观察利拉鲁肽联合胰岛素泵强化治疗对2型糖尿病合并肝硬化患者血糖代谢及肝纤维化的影响。方法 选择2017年1月~2018年6月山东医学高等专科学校附属医院收治的2型糖尿病合并肝硬化患者80例按随机数字表法分为对照组和实验组，每组40例。对照组给予单纯胰岛素泵控制血糖，实验组给予利拉鲁肽联合胰岛素泵强化治疗。观察两组患者治疗前后血清c肽、糖化血红蛋白、胰岛素敏感性指数、肝纤维化指标层黏连蛋白、透明质酸、Ⅲ型前胶原、Ⅳ型胶原变化。结果 治疗后，两组患者血清c肽水平、胰岛素敏感性指数均较治疗前升高，糖化血红蛋白较治疗前降低，差异有统计学意义（P＜0.05），实验组血清c肽水平、胰岛素敏感性指数较对照组高，糖化血红蛋白较对照组低，差异有统计学意义（P＜0.05）。治疗后，两组患者肝纤维化指标层黏连蛋白、透明质酸、Ⅲ型前胶原、Ⅳ型胶原均较治疗前降低，实验组肝纤维化指标层黏连蛋白、透明质酸、Ⅲ型前胶原、Ⅳ型胶原均较对照组低，差异有统计学意义（P＜0.05）。结论 2型糖尿病合并肝硬化患者治疗中，利拉鲁肽联合胰岛素泵强化治疗可以更加有效的控制血糖，改善胰岛素抵抗，降低肝脏纤维化水平，进而改善肝脏微环境，降低肝脏应激反应，促进肝脏纤维化的缓解。
Abstract:
Objective To observe the effects of intensive treatment with liraglutide combined with insulin pump on blood glucose metabolism and liver fibrosis in patients with type 2 diabetes mellitus complicated with cirrhosis.Methods From January 2017 to June 2018,80 patients with type 2 diabetes mellitus complicated with cirrhosis admitted to the affiliated hospital of Shandong Medical College were divided into control group and experimental group by random number table,40 cases in each group.The control group was given a simple insulin pump to control blood glucose,and the experimental group was given intensive treatment with liraglutide combined with insulin pump.The changes of serum c-peptide,glycosylated hemoglobin,insulin sensitivity index,liver fibrosis index laminin,hyaluronic acid,type III procollagen and type IV collagen were observed before and after treatment.Results After treatment, the serum c-peptide level and insulin sensitivity index of the two groups were higher than before treatment,and the glycated hemoglobin was lower than that before treatment,the difference was statistically significant(P<0.05).The serum c-peptide level and insulin sensitivity index of the experimental group were higher than those of the control group,and the glycated hemoglobin was lower than that of the control group,the difference was statistically significant(P<0.05).After treatment,the fibrin,hyaluronic acid,type III procollagen and type IV collagen in the liver fibrosis index of the two groups were lower than before treatment.In the experimental group,the fibrin,hyaluronic acid,type III procollagen and type IV collagen were lower than the control group,the difference was statistically significant(P<0.05).Conclusion In patients with type 2 diabetes mellitus complicated with cirrhosis,intensive treatment with liraglutide combined with insulin pump can more effectively control blood sugar,improve insulin resistance,reduce liver fibrosis, improve liver microenvironment,reduce liver stress response,and promote remission of liver fibrosis.

参考文献/References:

[1]Valderrábano RJ,Linares MI.Diabetes mellitus and bone health:epidemiology,etiology and implications for fracture risk stratification[J].Cardiovasc Diabetol,2018,25(3),4-9. [2]Lee G,Kim SM,Choi S,et al.The effect of change in fasting glucose on the risk of myocardial infarction,stroke,and all-cause mortality:a nationwide cohort study[J].Cardiovasc Diabetol, 2018,17(1):51-57. [3]Honda F,Hiramatsu A,Hyogo H,et al.Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring[J].PLoS One,2018, 13(4),22-31. [4]Korkmaz ,Demir G,etin H,et al.Effectiveness of tinuousbcutaneous insulin infusion pump therapy during five years of treatment on metabolic control in children and adolescents with Type 1 diabetes mellitus[J].J Clin Res Pediatr Endocrinol,2018,22(4),11-29. [5]Jaiswal M,Lauer A,Martin EL,et al.Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the search for Diabetes in Youth follow-up cohort:a pilot study[J].Diabetes Care,2013,36(12):3903-3908． [6]Cai X,Gao X,Yang W,et al.Comparisonbetweeninsulindegludec liraglutidetreatmentandinsulin glargine lixisenatidetreatmentintype 2 diabetes:asystematicreviewand meta-analysis[J]. Expertopin pharmacother,2017,18(17):1789-1798. [7]de Wit HM,Vervoort GMM,de Galan BE,et al.A cost-controlling treatment strategy ofadding liraglutidet oinsulinin type 2 diabetes[J].Neth J Med,2017,75(7):272-280. [8]SantilliF,SimeonePG,GuagnanoMT,et al．Effectsoflira-glutideonweightloss,fatdistribution,and βcellfunctionin obesesubjectswithpre diabetesorearlytype 2 diabetes[J].DiabetesCare, 2017,40(11),1556-1564. [9]Tasyurek HM,Altunbas HA,Balci MK,et al.Incretins:their physiology and application in the treatment of diabetes mellitus[J].Diabetes Metab Res Rev,2014,30(5):354-371. [10]翁建平.人胰高血糖素样肽-1受体激动剂的作用机制[J].中国老年学杂志,2015,21(6),24-28. [11]Petit JM,Cercueil JP,Loffroy R,et al.Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes:The Lira-NAFLD Study[J].The Journal of Clinical Endocrinology,2017,20(3):125-131.

相似文献/References:

[1]刘 静.利拉鲁肽联合基础胰岛素对初诊2型糖尿病合并肥胖患者 血糖控制及体质量指数的影响[J].医学信息,2018,31(13):137.[doi:10.3969/j.issn.1006-1959.2018.13.040]
　LIU Jing.Effect of Liraglutide Combined with Basal Insulin on Blood Glucose Control and Body Mass Index in Newly Diagnosed Type 2 Diabetes Patients with Obesity[J].Medical Information,2018,31(20):137.[doi:10.3969/j.issn.1006-1959.2018.13.040]
[2]房 芳,于 宏.利拉鲁肽联合二甲双胍治疗2型糖尿病的疗效观察[J].医学信息,2022,35(16):141.[doi:10.3969/j.issn.1006-1959.2022.16.036]
　FANG Fang,YU Hong.Effect of Liraglutide Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus[J].Medical Information,2022,35(20):141.[doi:10.3969/j.issn.1006-1959.2022.16.036]
[3]曾小兵,朱长东,谢宝强.利拉鲁肽对首诊2型糖尿病患者血糖、血脂及T细胞亚群的影响[J].医学信息,2019,32(22):125.[doi:10.3969/j.issn.1006-1959.2019.22.041]
　ZENG Xiao-bing,ZHU Chang-dong,XIE Bao-qiang.Effect of Liraglutide on Blood Glucose,Blood Lipids and T cell Subsets in Patients with Type 2 Diabetes Mellitus[J].Medical Information,2019,32(20):125.[doi:10.3969/j.issn.1006-1959.2019.22.041]
[4]蔡 玲.不同胰岛素给药模式对高龄妊娠期糖尿病患者血糖控制及母婴结局的影响[J].医学信息,2020,33(04):141.[doi:10.3969/j.issn.1006-1959.2020.04.045]
　CAI Ling.Effects of Different Insulin Administration Modes on Blood Glucose Control andMaternal and nfant Outcomes in Elderly Gestational Diabetes Mellitus Patients[J].Medical Information,2020,33(20):141.[doi:10.3969/j.issn.1006-1959.2020.04.045]
[5]王晓洲,吴仰帆,栾晓军.利拉鲁肽对肥胖T2DM患者促炎-抗炎系统及左心舒张功能的影响[J].医学信息,2021,34(22):145.[doi:10.3969/j.issn.1006-1959.2021.22.045]
　WANG Xiao-zhou,WU Yang-fan,LUAN Xiao-jun.Effects of Liraglutide on Pro-inflammatory-anti-inflammatory System and Left Ventricular Diastolic Function in Obese T2DM Patients[J].Medical Information,2021,34(20):145.[doi:10.3969/j.issn.1006-1959.2021.22.045]
[6]陶 蕾,张宏江,范中阳.利拉鲁肽联合胰岛素治疗肥胖2型糖尿病的疗效[J].医学信息,2021,34(23):99.[doi:10.3969/j.issn.1006-1959.2021.23.028]
　TAO Lei,ZHANG Hong-jiang,FAN Zhong-yang.Effect of Liraglutide Combined with Insulin in the Treatment of Obesity Type 2 Diabetes Mellitus[J].Medical Information,2021,34(20):99.[doi:10.3969/j.issn.1006-1959.2021.23.028]
[7]张 彤.利拉鲁肽联合胰岛素治疗新诊断肥胖2型糖尿病的临床疗效及安全性[J].医学信息,2022,35(05):159.[doi:10.3969/j.issn.1006-1959.2022.05.042]
　ZHANG Tong.Clinical Efficacy and Safety of Liraglutide Combined with Insulin in the Treatment of Newly Diagnosed Obese Type 2 Diabetes Mellitus[J].Medical Information,2022,35(20):159.[doi:10.3969/j.issn.1006-1959.2022.05.042]

更新日期/Last Update: 2018-11-09